Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Real-world patient-reported outcomes of breast cancer or prostate cancer patients receiving antiresorptive therapy for bone metastases: Final results of the PROBone registry studyJ Bone Oncol 2022 Apr 01;33(2022)100420, A Jakob, MO Zahn, A Nusch, T Werner, R Schnell, M Frank, N Hamm, KU Däßler, C Losem, M Welslau, P Hoevel, K Potthoff
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.